Position in MDCX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$13,380
New position
Shares Held
30,000
first reported quarter
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. MDCX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in MDCX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,380 | 30,000 | Shares | Defined | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||